Background: Hip fracture surgery may be associated with substantial blood loss. This study was designed to assess the efficacy and safety of the use of tranexamic acid in hip fracture surgery for the reduction of erythrocyte transfusion.
Methods: The study pertains to a randomized double-blind study with blinded adjudication of outcomes.